[ Price : $8.95]
Attorneys say generic drug companies are likely to sue FDA over its proposed rule to allow them to file labeling changes being eff...[ Price : $8.95]
Federal Register Notice: FDA seeks public comments on information collection provisions for petitions requesting an exemption from...[ Price : $8.95]
Federal Register Notice: FDA seeks comments on its patent term restoration regulations and petitions for regulatory review period ...[ Price : $8.95]
The co-chairs of the congressional Childhood Cancer Caucus ask FDA commissioner Margaret Hamburg what the agency is doing to elimi...[ Price : $8.95]
Procter & Gamble asks FDA to ensure that labeling for any OTC proton pump inhibitor is similar to that approved for Prilosec OTC.[ Price : $8.95]
AstraZeneca plans to begin two new clinical trials of its Brilinta in patients who have had an acute ischemic stroke or TIA and in...[ Price : $8.95]
Alkermes asks FDA to amend its draft bioequivalence recommendations for risperidone intramuscular injection (Janssens antipsychoti...[ Price : $8.95]
CDER Office of New Drug Quality Assessment acting director Christine Moore says that while quality-by-design principles have been ...